MiniMed Group, Inc. (MMED) Stock Analysis
Healthcare · Health Information Services
Sell if holding. Momentum 2.0/10 is below the 5.0 floor at $12.34 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Leverage penalty (D/E 1.8): -1.0; Negative momentum.
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, including insulin pumps and pens, continuous glucose... Read more
Sell if holding. Momentum 2.0/10 is below the 5.0 floor at $12.34 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Leverage penalty (D/E 1.8): -1.0; Negative momentum. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Score 5.6/10, moderate confidence.
Passes 5/6 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, earnings proximity 34d clear, semi cycle peak clear). Fails on weak momentum. Suitability: aggressive.
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
2 floor-breakers
Momentum below the gate floor. Component breakdown shows what dragged the score down.static
No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Momentum 2.0/10 is below the 5.0 floor at $12.34 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Leverage penalty (D/E 1.8): -1.0; Negative momentum. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Prior stop was $11.65. Score 5.6/10, moderate confidence.
Take-profit target: $19.54 (+58.0% upside). Prior stop was $11.65. Stop-loss: $11.65.
Leverage penalty (D/E 1.8): -1.0; Negative momentum; Elevated risk factors.
MiniMed Group, Inc. trades at a P/E of N/A (forward 17.9). TrendMatrix value score: 7.7/10. Verdict: Sell.
What does MiniMed Group, Inc. do?MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment...
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, including insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera, or Guardian 4, and wraparound applications and services. MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California.